Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease

被引：0
|
作者：
Lee, Kelvin H. [1 ]
Relkin, Norman R. [1 ]
机构：
[1] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
来源：
ANNALS OF NEUROLOGY | 2007年 / 61卷 / 05期
关键词：
D O I：
10.1002/ana.21126
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：497 / 498
页数：2
相关论文
共 50 条
  • [31] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [32] Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease
    Olsson, Martin
    Arlig, Johan
    Hedner, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    SLEEP, 2018, 41 (05)
  • [33] Cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
    Kolupaeva, E.
    Zhukova, I.
    Zhukova, N.
    Alifirova, V.
    Izhboldina, O.
    Mironova, Y.
    Latypova, A.
    Nikitina, M.
    Titova, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 673 - 673
  • [34] To tap or not to tap: Cerebrospinal fluid biomarkers of Alzheimer's disease
    Growdon, JH
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 6 - 7
  • [35] The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease
    Engelborghs, Sebastiaan
    Le Bastardl, Nathalie
    MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (03) : 135 - 141
  • [36] Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
    Skogseth, Ragnhild
    Mulugeta, Ezra
    Ballard, Clive
    Rongve, Arvid
    Nore, Sabine
    Alves, Guido
    Aarsland, Dag
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (06) : 559 - 563
  • [37] Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
    Riekse, Robert G.
    Li, Ge
    Petrie, Eric C.
    Leverenz, James B.
    Vavrek, Darcy
    Vuletic, Simona
    Albers, John J.
    Montine, Thomas J.
    Lee, Virginia M. -Y.
    Lee, Michael
    Seubert, Peter
    Galasko, Douglas
    Schellenberg, Gerard D.
    Hazzard, William R.
    Peskind, Elaine R.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 10 (04) : 399 - 406
  • [38] Alzheimer's disease cerebrospinal fluid biomarker discovery: A proteomics approach
    D'Ascenzo, M
    Relkin, NR
    Lee, KH
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (06) : 557 - 564
  • [39] Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics
    Tijms, Betty M.
    Gobom, Johan
    Reus, Lianne
    Jansen, Iris
    Hong, Shengjun
    Dobricic, Valerija
    Kilpert, Fabian
    ten Kate, Mara
    Barkhof, Frederik
    Tsolaki, Magda
    Verhey, Frans R. J.
    Popp, Julius
    Martinez-Lage, Pablo
    Vandenberghe, Rik
    Lle, Alberto
    Molinuevo, Jose Luis
    Engelborghs, Sebastiaan
    Bertram, Lars
    Lovestone, Simon
    Streffer, Johannes
    Vos, Stephanie
    Bos, Isabelle
    Blennow, Kaj
    Scheltens, Philip
    Teunissen, Charlotte E.
    Zetterberg, Henrik
    Visser, Pieter Jelle
    BRAIN, 2020, 143 : 3776 - 3792
  • [40] Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease
    Higginbotham, Lenora
    Ping, Lingyan
    Dammer, Eric B.
    Duong, Duc M.
    Zhou, Maotian
    Gearing, Marla
    Hurst, Cheyenne
    Glass, Jonathan D.
    Factor, Stewart A.
    Johnson, Erik C. B.
    Hajjar, Ihab
    Lah, James J.
    Levey, Allan, I
    Seyfried, Nicholas T.
    SCIENCE ADVANCES, 2020, 6 (43)
12345